These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9285305)

  • 1. Pharmacotherapy of benign prostatic hyperplasia: inhibitor of 5 alpha-reductase.
    Polat O; Ozbey I; Gül O; Demirel A; Bayraktar Y
    Int Urol Nephrol; 1997; 29(3):323-30. PubMed ID: 9285305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5alpha-reductase inhibitors/finasteride.
    Stoner E
    Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of finasteride in benign prostatic hyperplasia: a randomized double-blind controlled trial.
    Yu HJ; Chiu TY; Lai MK
    J Formos Med Assoc; 1995; 94(1-2):37-41. PubMed ID: 7542109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
    Denti L; Pasolini G; Cortellini P; Sanfelici L; Benedetti R; Cecchetti A; Ferretti S; Banchini A; Ablondi F; Valenti G
    J Endocrinol Invest; 1999; 22(10 Suppl):70-1. PubMed ID: 10727053
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.
    Carraro JC; Raynaud JP; Koch G; Chisholm GD; Di Silverio F; Teillac P; Da Silva FC; Cauquil J; Chopin DK; Hamdy FC; Hanus M; Hauri D; Kalinteris A; Marencak J; Perier A; Perrin P
    Prostate; 1996 Oct; 29(4):231-40; discussion 241-2. PubMed ID: 8876706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K
    J Urol; 1998 Oct; 160(4):1358-67. PubMed ID: 9751354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign prostatic hyperplasia--its treatment with Proscar].
    Panchev P; Neĭkov K; Simeonov P
    Khirurgiia (Sofiia); 1996; 49(1):15-8. PubMed ID: 8975081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of finasteride in the treatment of symptomatic benign prostatic hyperplasia.
    Wu TT; Lee YH; Jiaan BP; Huang JK
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):399-403. PubMed ID: 8851481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
    Stepanov VN; Teodorovich OV; Seregin AV; Kadyrov ZA
    Urol Nefrol (Mosk); 1995; (5):28-30. PubMed ID: 8571480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic expression of human 5alpha-reductase type 2 during finasteride therapy: a randomized, double-blind, placebo-controlled study.
    Vaarala MH; Lukkarinen O; Marttila T; Kyllönen AP; Porvari KS; Vihko PT
    World J Urol; 2000 Dec; 18(6):406-10. PubMed ID: 11204259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proscar: five-year experience.
    Moore E; Bracken B; Bremner W; Geller J; Imperato-McGinley J; McConnell J; Roy J; Tenover L; Vaughan D; Pappas F
    Eur Urol; 1995; 28(4):304-9. PubMed ID: 8575497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group.
    Marberger MJ
    Urology; 1998 May; 51(5):677-86. PubMed ID: 9610579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P; Andersen JT; Wolf H
    Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA
    Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating benign prostatic hyperplasia with finasteride in Chinese men: one-year experience.
    Chueh SC; Yu HJ; Chiu TY; Huang CY; Lai MK
    J Formos Med Assoc; 1996 Aug; 95(8):650-2. PubMed ID: 8870441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of different drugs on the treatment of benign prostate hyperplasia].
    Li NC; Wu SL; Jin J; Qiu SP; Kong CZ; Song YS; Ye ZQ; Sun G; Sun YH; Sun YC; Wang XF; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):947-50. PubMed ID: 17961376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group.
    Andersen JT; Ekman P; Wolf H; Beisland HO; Johansson JE; Kontturi M; Lehtonen T; Tveter K
    Urology; 1995 Nov; 46(5):631-7. PubMed ID: 7495111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
    Nickel JC; Fradet Y; Boake RC; Pommerville PJ; Perreault JP; Afridi SK; Elhilali MM
    CMAJ; 1996 Nov; 155(9):1251-9. PubMed ID: 8911291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.